Overfitting presents a significant challenge in 3D-QSAR modeling, often leading to non-predictive models and failed optimizations in anticancer drug discovery.
This article provides a comprehensive guide for researchers and drug development professionals on optimizing Partial Least Squares (PLS) components to enhance the predictive power and reliability of 3D-QSAR models.
Activity cliffs (ACs), where minute structural modifications cause drastic potency shifts, represent a critical source of prediction error in quantitative structure-activity relationship (QSAR) modeling, often leading to failures in lead...
This article provides a comprehensive exploration of virtual screening utilizing 3D-QSAR models for the discovery of glioblastoma therapeutics.
This article provides a detailed computational protocol for applying Comparative Molecular Field Analysis (CoMFA) and Comparative Molecular Similarity Indices Analysis (CoMSIA) to design and optimize pteridinone-based Polo-like kinase 1 (PLK1)...
This article provides a comprehensive guide to the foundational principles and advanced applications of Three-Dimensional Quantitative Structure-Activity Relationship (3D-QSAR) modeling in the discovery and optimization of natural product-based anticancer compounds.
This article provides a comprehensive guide for researchers and drug development professionals on implementing field-based 3D-QSAR to accelerate the discovery of novel tumor inhibitors.
This comprehensive review elucidates the critical role of molecular descriptors in Quantitative Structure-Activity Relationship (QSAR) studies for anticancer drug development.
This article provides a comprehensive overview of the integrated application of Quantitative Structure-Activity Relationship (QSAR) modeling and molecular docking in breast cancer research.
This article provides a comprehensive overview of pharmacophore modeling and its pivotal role in modern oncology drug discovery.